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Abstract
Antimicrobial  effects  of  essential  oils  against  bacteria  associated  with  urinary 
catheter  infection  was  assessed.  Tests were  performed on  14  different  bacterial 
species cultured either planktonically or as biofilms. Biofilms were found to be up to 
8-fold  more  tolerant  of  the  test  agents.  Higher  antimicrobial  tolerance  was  also 
evident in tests conducted in artificial urine. Eugenol exhibited highest antimicrobial 
effects against both planktonic cells and biofilms when compared with terpinen, tea 
tree oil and cineole. 
(73 words, cannot exceed 75 words)
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Foley catheters are frequently used to drain urine from the bladder of patients with 
urinary  incontinence  or  neurological  dysfunction.  Whilst  providing  a  valuable 
function,  urinary  catheters  also  provide  access  for  microorganisms  to  infect  the 
bladder and also undermine the basic host defences of the urinary tract. Importantly,  
catheter-associated urinary tract infections (CAUTIs) represent the most frequently 
encountered hospital  acquired infection (1).  Proteus mirabilis  is  a urease positive 
bacterium that  raises  urine  pH  during  infection.  This  allows  struvite  and  apatite 
crystal encrustation of the catheter which obstructs urine flow, potentially promoting 
serious clinical complications. All currently available catheters are vulnerable to this 
encrustation and there is no single effective preventative strategy (2-4). 
Due to the increasing prevalence of antibiotic resistance, interest has arisen in the 
therapeutic  use  of  alternative  medicines  in  combating  infection  (5-9).  Naturally-
occurring biocides are effective in inactivating a wide variety of microorganisms as 
they often target multiple bacterial sites and as such, are less prone to development 
of resistance compared with antibiotics (10, 11). One possible approach to prevent 
catheter encrustation would be to incorporate these biocides into catheter wash-out 
solutions, into the catheter material itself or use the catheter retention balloon as a 
reservoir for the delivery of the antimicrobial agent into the catheterised bladder (12-
16).  Little  is  currently  known  about  the  susceptibility  of  Proteus to  natural 
antimicrobial agents hence the aim of this study was to examine antimicrobial activity 
of several essential oils, namely tea tree oil, terpinen, cineole, and eugenol, against 
P. mirabilis and other urease producing bacteria involved in CAUTIs. Activity of these 
agents was tested against both planktonic cells and biofilms, as the latter frequently 
exhibits enhanced resistance to traditional antimicrobials.  
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The isolates used in this study are presented in Table 1. The antimicrobial agents 
tested were cineole, tea tree oil (TTO), terpinen, and eugenol. Overnight cultures of 
test  isolates were prepared in Mueller  Hinton Broth (MHB) (17) or  artificial  urine 
adjusted to pH 6.1,  and containing 1% Tryptone Soya Broth (TSB)(18).  Cultures 
were  adjusted  to  a  0.5  MacFarland  standard  (approximately  108 cells  ml-1)  and 
diluted 100-fold in MHB or artificial urine. Serial dilutions of the antimicrobial agents 
were prepared in MHB or artificial urine supplemented with 0.002% (v/v) Tween 80 
(Sigma Aldrich, UK). A 100-µl  volume of each dilution of antimicrobial  agent was 
added  to  an  equal  volume  of  microbial  suspension,  giving  antimicrobial 
concentrations  ranging  from  0.008  to  8%  (v/v).  Controls  included  bacterial 
suspensions containing no antimicrobial agent and uninoculated culture media. The 
bacteria and antimicrobial agent were co-incubated aerobically in 96-well microtitre 
plates  for  24 h at  37˚C.  Microbial  growth was determined by spectrophotometric 
analysis  (620nm).  Absorbance  readings  were  standardised  against  ‘microbial-free’ 
antimicrobial agent controls. The minimal inhibitory concentration (MIC) was defined 
as the lowest concentration of antimicrobial agent which resulted in ≥80% reduction 
in absorbance compared to the antimicrobial-free controls (19). 
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A biofilm susceptibility test was also performed using the isolates described in Table 
1. Isolates were incubated as described above, but  without  agitation to allow for 
biofilm formation. Culture medium was removed and the biofilms were washed with 
100-μl  phosphate buffered saline (PBS) to remove planktonic cells.  Fresh culture 
medium (100 µl), containing antimicrobial agent at concentrations ranging from 0.008 
to 8% (v/v), was added to each well. Controls, as previously described, were also 
included. Biofilms were incubated in the presence of antimicrobial  agent for 24 h 
without agitation under the conditions described above before the supernatant was 
removed and the biofilm washed (×1) with  PBS. Fresh culture medium (100  µl), 
which did not  contain antimicrobial  agent,  was added to the biofilms which were 
disrupted by repeated pipetting. The turbidity (620nm) of the re-suspended biofilm was 
measured and again after incubation at 37°C for an additional 6 h and 24 h. The 
relative growth of microorganisms was determined by the change in absorbance and 
antibiofilm activity recorded as the lowest concentration of agent that demonstrated a 
≥80%  reduction  in  absorbance  compared  to  the  control.  All  experiments  were 
performed in triplicate on 3 separate occasions in MHB and artificial urine. 
A summary of the results is presented in Table 1. Cineole and TTO had the lowest  
antimicrobial activity against bacteria grown in MHB and were therefore not tested in 
artificial urine. Highest antimicrobial activity by the essential oils against planktonic 
growth in MHB occurred with eugenol and terpinen. However, when tested in artificial 
urine,  the  activity  of  terpinen  was  noticeably  reduced.  There  was  also  a  higher 
tolerance of biofilms (up to 8-fold) to most of the essential oils compared with their 
planktonic  equivalents.  This  increased  biofilm  resistance  was  least  evident  with 
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eugenol in MHB, but was apparent with eugenol (up to 32-fold) against biofilms in 
artificial urine. 
Urinary catheters provide a convenient means to drain urine from the bladder of 
patients suffering from urinary incontinence or neurological  dysfunction.  However, 
they are also associated with complications, as they provide access for bacteria from 
a heavily contaminated external skin site to the bladder and kidneys (20). Catheters 
also undermine the normal  filling and emptying of  the bladder  which flushes out 
microorganisms that might be contaminating the urethra. Furthermore, a reservoir of 
residual  urine remains in the bladder of  catheterised patients,  allowing continued 
proliferation  of  contaminating  organisms (21).  CAUTIs  are  usually asymptomatic, 
and because of the danger of promoting antibiotic resistance, catheter associated 
bacteriuria is generally not treated with antibiotics (22-24). Elimination of P. mirabilis 
by appropriate  therapy as  soon as  it  enters  the  catheterised urinary tract  would 
reduce the incidence of CAUTIs and improve the quality of life for many patients, 
whilst also reducing the costs of managing the complications of catheter encrustation 
and blockage (25). Several management and treatment strategies for CAUTIs have 
been  used,  including  limiting  catheter  use,  removal  of  the  catheter  as  soon  as 
possible,  maintaining  a  closed  drainage  system,  and  use  of  alternative  catheter 
surfaces with anti-infective agents (23, 26). Unfortunately, no single effective strategy 
for prevention of CAUTIs has yet been identified. 
The purpose of this study was to assess the antimicrobial activity of several essential  
oils against bacteria involved in CAUTIs. Based on these findings, further studies are 
planned  to  incorporate  these  agents  into  urinary  catheter  materials  to  prevent 
infection.  The  results  of  this  study  show  that  TTO,  terpinen-4-ol,  eugenol  and 
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triclosan  possessed  antimicrobial  activity  against  the  majority  of  the  organisms 
tested in planktonic growth. A greatly reduced antimicrobial activity was, however, 
noted when used to  combat  biofilms.  The exception  to  this  was  eugenol,  which 
retained much of its activity against biofilms cultured in MHB. Recently, eugenol’s 
antibacterial activity against  P. mirabilis  was highlighted by Devi  et al. (2013), who 
demonstrated that eugenol altered the cell membrane integrity of  P. mirabilis  (27). 
Our  data also strengthens previous research regarding TTO activity,  in particular 
terpinen-4-ol, as the single active constituent of TTO, and its activity in vivo (9, 28, 
29). 
Whilst in our study, biofilms were more tolerant to these natural agents compared 
with planktonic cells, sufficient antimicrobial effects were observed to warrant further 
investigation into the clinical potential of these agents. These observations should 
encourage  clinical  studies  to  examine  the  effect  of  washout  solutions  on  the 
blockage  of  long  term  catheterised  patients.  An  alternative  approach  is  the 
incorporation  of  these  agents  into  biomaterials  used  in  catheter  development, 
thereby generating a catheter surface which could inhibit the growth and swarming of 
P. mirabilis. There is the potential advantage to using such agents prophylactically 
compared  to  antibiotics  (i.e as  they  would  not  encourage  the  development  of 
antibiotic resistant organisms). 
In conclusion, this study suggests that triclosan, terpinen-4-ol  and eugenol  inhibit 
growth and swarming of P. mirabilis and may prove clinically useful for the treatment 
of  CAUTIs.  However,  more  work  is  needed to  validate  the  biocides for  washout 
solutions or their incorporation into urinary catheters.
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